Company: VERA
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029969
Chunk: 13

Company: Vera Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 16
Chunk 13
---
32.1 and 32.2 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (including this Annual Report on Form 10-K), unless the Registrant specifically incorporates the foregoing information into those documents by reference. 

128

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

    Vera Therapeutics, Inc.

    Date: February 28, 2025
     
    By:
    /s/ Marshall Fordyce

    Marshall Fordyce, M.D.

    President, Chief Executive Officer and Director(Principal Executive Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

    Name
     
    Title
     
    Date

    /s/ Marshall Fordyce
     
    President, Chief Executive Officer and Director
     
    February 28, 2025

    Marshall Fordyce, M.D.
     
    (Principal Executive Officer)

    /s/ Sean Grant
     
    Chief Financial Officer
     
    February 28, 2025

    Sean Grant
     
    (Principal Financial Officer)

    /s/ Joseph Young
     
    Senior Vice President, Finance and Chief Accounting Officer
     
    February 28, 2025

    Joseph Young
     
    (Principal Accounting Officer)

    /s/ Michael Morrissey
     
    Chairman of the Board
     
    February 28, 2025

    Michael Morrissey, Ph.D.

    /s/ Andrew Cheng
     
    Director
     
    February 28, 2025

    Andrew Cheng, M.D., Ph.D.

    /s/ Patrick Enright
     
    Director
     
    February 28, 2025

    Patrick Enright

    /s/ Kimball Hall
     
    Director
     
    February 28, 2025

    Kimball Hall

    /s/ Maha Katabi
     
    Director